Komori
Financial results presentation6340SHIBUYA CORPORATIONMachinery

Financial Results Presentation Materials for the Fiscal Year Ending June 2026

For the fiscal year ending June 2026, revenue and net income reached record highs, while revenue and operating profit exceeded the initial plan. However, operating profit and ordinary profit were lower than in the previous fiscal year due to increases in raw material costs, personnel expenses, depreciation and amortization, and other costs. For the fiscal year ending June 2027, the company expects higher revenue and profit.

Worth reading
70In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
6596
¥ million (year-on-year increase in net sales)
Wording
Conditional
How definitive the wording is.

Contents of this document

Financial results presentationFiscal year ending June 202614 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥135,613 million+5.1%
Operating profit¥13,081 million-4.9%
Ordinary income¥13,560 million-1.5%
Net income¥10,223 million +1.7%net income attributable to owners of the parent
Gross Profit Margin18.6 %
Operating profit margin9.6 %
Selling, general and administrative expenses¥12,155 million
Results for the three months of the current quarter
Net Sales
¥39,091 million+11.5%
Operating profit
¥4,866 million+58.2%
Full-year earnings forecast
Net Sales
¥150,000 million
Operating profit
¥16,000 million
Ordinary income
¥16,200 million
Net income
¥11,000 million net income attributable to owners of the parent
EPS
¥397.6
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
For the fiscal year ending June 2026, both revenue and operating profit met the initial targets. The medium-term numerical targets were slightly missed.
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
  • Increase in gross profit from higher sales¥1,325 million
  • Decline in Gross Profit Margin¥-1,320 million
  • Increase in SG&A expenses¥-697 million
  • Decrease in R&D expenses¥25 million
New initiatives
  • Deployment of the next-generation SHoPS platform
  • Planned establishment of the MIRAI Tech Lab
  • Validation of elemental technologies for the introduction of physical AI
  • Development of Shibuya Connect
  • Planned establishment of a local subsidiary in India
  • Development of a laser microfabrication system for high-performance glass with 4JET
  • AI sorting system for potatoes
  • Solid-liquid mixing and dispersion systems
  • Automated cell-culture system for autologous cell banks
  • End-to-end manufacturing DX project
  • Production capacity expansion investments at 4 plants
Key KPIsA metric the company considers important as a management benchmark.
  • Orders receivedUp 10.4% year on year
    Year on year against the same period last year+10.4%
  • Order backlogDown 2.9% year on year
    Year on year against the same period last year-2.9%
  • Domestic revenue¥80,271 million
    Year on year against the same period last year+6.1%
  • Overseas revenue¥55,342 million
    Year on year against the same period last year+3.7%
  • PBR1.03 times
  • ROE9 %
    Year on year against the same period last year-0.6%
Segment results
  • Packaging Plant Business
    Net Sales¥84,041 million (YoY +4.9%)
    Operating profit¥13,239 million (YoY +5.3%)
  • Mechatronics Systems Business
    Net Sales¥38,997 million (YoY +3.3%)
    Operating profit¥1,781 million (YoY -23.9%)
  • Agricultural Equipment Business
    Net Sales¥12,574 million (YoY +12.6%)
    Operating profit¥520 million (YoY -50.1%)
Medium-term management plan targets
Fiscal year ending June 2027
Net Sales¥1,500 100 million
Operating profit¥160 100 million
Unit_Operating profit¥100 million
ROE10% or higher
Fiscal year ending June 2030
Consolidated revenue¥2,000 100 million
Financial targets
ROE
Target10% or higher
Actual results9.0%
PBR
Actual results1.03 times
Market Size / Share
  • Global dialysis marketUS$103.1 billion in 2025 to US$220.7 billion in 2034
  • Advanced semiconductors for data centersUS$4.0 billion in 2025, US$4.8 billion in 2026, and US$5.6 billion in 2027
  • Global PET bottled beverage marketExpected to grow by approximately 5% annually through 2033
Orders received and order backlog
Amounts are not disclosed. Orders received increased 10.4% year on year, while the order backlog decreased 2.9% year on year.
Number of employees
Hiring and changes during the period
  • 49 female career-track hires (cumulative)
  • 56 hires from NITTE University (cumulative)
Capital expenditures
¥10.7 billion for the SX Morimoto Plant, ¥1.7 billion for the Morimoto No. 3 Machinery Plant, ¥4.5 billion for the Nomi No. 2 Machinery Plant, and ¥3.5 billion for Building B of the Wakamiya Medical Equipment Plant
Annual Dividend
Fiscal year ending June 2026
¥100 per share
Fiscal year ending June 2027
Annual¥120 per share
Interim¥55 per share
End of period¥65 per share
Payout ratio
30% or higher (medium-term plan target) / 30% expected (fiscal year ending June 2027)
Acquisition of treasury shares
The company plans to conduct buybacks flexibly. The buyback limit, number of shares and period are not disclosed.
Contents of this document
ItemDetails
Document typeFinancial results presentation
Fiscal Period CoveredFiscal year ending June 2026
Net Sales¥135,613 million (YoY +5.1%)
Operating profit¥13,081 million (YoY -4.9%)
Ordinary income¥13,560 million (YoY -1.5%)
Net income¥10,223 million (net income attributable to owners of the parent) (YoY +1.7%)
Gross Profit Margin18.6 %
Operating profit margin9.6 %
Selling, general and administrative expenses¥12,155 million
Results for the three months of the current quarterNet Sales ¥39,091 million (YoY +11.5%) / Operating profit ¥4,866 million (YoY +58.2%)
Full-year earnings forecastNet Sales ¥150,000 million / Operating profit ¥16,000 million / Ordinary income ¥16,200 million / Net income ¥11,000 million (net income attributable to owners of the parent) / EPS ¥397.6
Self-assessment against the planFor the fiscal year ending June 2026, both revenue and operating profit met the initial targets. The medium-term numerical targets were slightly missed.
Segment resultsSegment Packaging Plant Business / Net Sales ¥84,041 million (YoY +4.9%) / Operating profit ¥13,239 million (YoY +5.3%), Segment Mechatronics Systems Business / Net Sales ¥38,997 million (YoY +3.3%) / Operating profit ¥1,781 million (YoY -23.9%), Segment Agricultural Equipment Business / Net Sales ¥12,574 million (YoY +12.6%) / Operating profit ¥520 million (YoY -50.1%)
Breakdown of Factors Affecting the ChangeFactors Increase in gross profit from higher sales / Amount ¥1,325 million, Factors Decline in Gross Profit Margin / Amount ¥-1,320 million, Factors Increase in SG&A expenses / Amount ¥-697 million, Factors Decrease in R&D expenses / Amount ¥25 million
Key KPIsIndicator name Orders received / Value Up 10.4% year on year / Year on year against the same period last year 10.4 %, Indicator name Order backlog / Value Down 2.9% year on year / Year on year against the same period last year -2.9 %, Indicator name Domestic revenue / Value ¥80,271 million / Year on year against the same period last year ¥6.1 million, Indicator name Overseas revenue / Value ¥55,342 million / Year on year against the same period last year ¥3.7 million, Indicator name PBR / Value 1.03 times / Year on year against the same period last year Not disclosed, Indicator name ROE / Value 9 % / Year on year against the same period last year -0.6 %
Number of employeesNumber of Employees Not disclosed / Hiring and changes during the period 49 female career-track hires (cumulative), 56 hires from NITTE University (cumulative)
Medium-term management plan targetsFiscal year ending June 2027 Net Sales ¥1,500 100 million / Operating profit ¥160 100 million / Unit_Operating profit ¥100 million / ROE 10% or higher / Fiscal year ending June 2030 Consolidated revenue ¥2,000 100 million
Financial targetsROE Target 10% or higher / Actual results 9.0% / PBR Actual results 1.03 times
Annual DividendFiscal year ending June 2026 ¥100 per share / Fiscal year ending June 2027 Annual ¥120 per share / Interim ¥55 per share / End of period ¥65 per share
Payout ratio30% or higher (medium-term plan target) / 30% expected (fiscal year ending June 2027)
Acquisition of treasury sharesThe company plans to conduct buybacks flexibly. The buyback limit, number of shares and period are not disclosed.
Capital expenditures¥10.7 billion for the SX Morimoto Plant, ¥1.7 billion for the Morimoto No. 3 Machinery Plant, ¥4.5 billion for the Nomi No. 2 Machinery Plant, and ¥3.5 billion for Building B of the Wakamiya Medical Equipment Plant
Orders received and order backlogAmounts are not disclosed. Orders received increased 10.4% year on year, while the order backlog decreased 2.9% year on year.
Market Size / ShareGlobal dialysis market US$103.1 billion in 2025 to US$220.7 billion in 2034, Advanced semiconductors for data centers US$4.0 billion in 2025, US$4.8 billion in 2026, and US$5.6 billion in 2027, Global PET bottled beverage market Expected to grow by approximately 5% annually through 2033
New initiativesDeployment of the next-generation SHoPS platform, Planned establishment of the MIRAI Tech Lab, Validation of elemental technologies for the introduction of physical AI, Development of Shibuya Connect, Planned establishment of a local subsidiary in India, Development of a laser microfabrication system for high-performance glass with 4JET, AI sorting system for potatoes, Solid-liquid mixing and dispersion systems, Automated cell-culture system for autologous cell banks, End-to-end manufacturing DX project, Production capacity expansion investments at 4 plants
Items this document does not state (6)
Progress against full-year forecastUnit price and quantity metricsNumber of stores and locationsAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Although revenue increased, variable and fixed costs rose due to higher raw material prices and increases in personnel expenses and depreciation and amortization, resulting in lower operating profit. Additional costs associated with replacing medical-equipment components and several low-margin large-scale plant projects also contributed to the decline in profit.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Financial Results Presentation Materials for the Fiscal Year Ending June 2026 | SHIBUYA CORPORATION (6340) timely disclosure | Komori